Loading…
Employees: 2,826
Size Valhi (VHI) is a United States Materials company (Chemicals: Specialty) with a market value of $456M, the 2764th largest of 3,117 United States companies the cockpit tracks. Shares closed at $16.10 on 6 Nov 2026.
Performance Over six months the shares gained 11.1%, against -16.3% for the median peer and -1.1% for the United States market (cap-weighted) — 4th highest of 21 in its peer set.
Growth Revenue grew 3.4% over the last twelve months (peer median +11.5%); the operating margin is 0.5% (peer median 4.4%).
Valuation It trades at 4.6× forward earnings against a peer median of 17.9× (2nd cheapest of 8).
Price implies For today's price to make sense, revenue must grow about 32% a year for seven years (Req g). Recent delivered growth is +2%, so the hurdle is +30 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 7.1 points below its cost of capital (7.6% WACC).
Short interest Short interest is 0.2% of the free float (15 Oct 2026).
Next results Next results expected around 11 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $2.16B | $2.08B | $2.10B | $1.92B | $2.22B |
| Revenue growth | — | -1% | +10% | -14% | — |
| Gross profit | $318M | $306M | $426M | $245M | $490M |
| EBITDA | $82.4M | $65.4M | $261M | $34.6M | $245M |
| Net income | -$51.1M | -$57.6M | $108M | -$9.90M | $90.2M |
| Free cash flow | $62.7M | -$82.1M | $13.1M | -$44.6M | -$32.7M |
| Capital expenditure | $49.0M | $46.6M | $30.9M | $48.5M | $67.6M |
| Total debt | $607M | $612M | $584M | $569M | $581M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | VHI | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +8.0% | -11.4% | highest of 21 |
| 6-month return | +11.1% | -16.3% | 4th highest of 21 |
| Distance from 52-week high | -16.1% | -39.3% | 3rd highest of 21 |
| Revenue growth (TTM) | +3.4% | +11.5% | 8th lowest of 21 |
| Operating margin | 0.5% | 4.4% | 6th lowest of 21 |
| Forward P/E | 4.6× | 17.9× | 2nd cheapest of 8 |
| Growth the price implies (Req g, 7 yrs) | 32.2% | 9.3% | 4th most demanding of 17 |
| Growth delivered (Del g) | +2.3% | +6.4% | 5th lowest of 17 |
| Hurdle (Req g minus delivered) | +29.8 pp | -6.6 pp | 2nd most demanding of 17 |
| ROIC minus cost of capital | -7.1 pp | -1.8 pp | 7th lowest of 21 |
| Net debt / EBITDA | 4.7× | 0.5× | 3rd most indebted of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Valhi VHI | United States | $456M | +11% | +3% | 1% | 4.6× | 32.2% | +2.3% |
| Braskem S.A. Sponsored ADR Pfd BAK | United States | $457M | -70% | -1% | 1% | 1.0× | n/a | n/a |
| Advansix ASIX | United States | $454M | -17% | +8% | -1% | 90.9× | 55.3% | +5.6% |
| Ho Tung Chemical 1714.TW | Taiwan | $459M | +67% | +36% | 10% | n/a | -17.3% | -1.5% |
| FuJian Nox Bellcow 300132.SZ | China | $459M | -37% | +18% | 7% | 17.9× | 3.1% | -10.5% |
| Changhua Chemical Technology 301518.SZ | China | $452M | -45% | +17% | -2% | n/a | n/a | n/a |
| JSP 7942.T | Japan | $462M | +29% | +14% | 8% | 9.9× | -4.0% | +7.2% |
| Nantong Jiangtian Chemical 300927.SZ | China | $463M | -29% | +51% | 5% | n/a | 18.0% | +29.0% |
| Lee & Man Chemical 0746.HK | Hong Kong | $465M | -9% | +3% | 18% | 6.1× | -8.5% | +3.9% |
| Dymatic Chemicals 002054.SZ | China | $465M | -25% | +21% | 8% | n/a | -0.8% | +12.9% |
| Kente Catalysts 603120.SS | China | $465M | +6% | +9% | 12% | n/a | 18.3% | -8.9% |
| Renxin New Material 301395.SZ | China | $445M | -10% | +1% | -6% | n/a | n/a | n/a |
| UPC Technology 1313.TW | Taiwan | $445M | +4% | -1% | -23% | n/a | -2.6% | +2.5% |
| Shenyang Chemical Industry 000698.SZ | China | $445M | -6% | +18% | 1% | n/a | n/a | n/a |
| Qingdao Copton Technology 603798.SS | China | $443M | -36% | -12% | 5% | n/a | 28.5% | +0.9% |
| Shaanxi Xinghua Chemistry 002109.SZ | China | $473M | -39% | +20% | -1% | n/a | 2.0% | +13.0% |
| Zhejiang Hisun Biomaterials 688203.SS | China | $473M | +16% | +47% | 4% | 56.0× | 16.5% | +26.6% |
| Gujarat Alkalies & Chemicals GUJALKALI.NS | India | $476M | -23% | +7% | 2% | n/a | 39.8% | +12.5% |
| Shanghai Huide Science & Technology 603192.SS | China | $476M | -15% | +2% | 3% | n/a | 15.5% | +10.5% |
| Zhejiang Jianye Chemical 603948.SS | China | $436M | -35% | -5% | 12% | n/a | -4.5% | +3.5% |
| Ellenbarrie Industrial Gases ELLEN.NS | India | $434M | 0% | +289% | 28% | 25.3× | 43.5% | +14.3% |